DBCO-PEG3-paclitaxel
Dibenzocyclooctyne-PEG3-paclitaxel
| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
|---|---|---|---|---|
| R-M2-9650 | 25mg | 950.00 | + Add to cart |
|
| R-M2-9650 | 50mg | 1689.00 | + Add to cart |
|
|
|
||||
Product description
DBCO-PEG3-paclitaxel,Dibenzocyclooctyne-PEG3-paclitaxel can be used to deliver multiple agents simultaneously, enhancing therapeutic efficacy. For instance, an azide-bearing drug can be linked to the DBCO group to create a dual-action therapy.The DBCO moiety allows for the selective attachment of targeting ligands (like antibodies or small molecules) that can deliver paclitaxel specifically to cancer cells, reducing the impact on healthy tissues.
| Appearance | N/A |
|---|---|
| Molecular Weight | N/A |
| Molecular formula | N/A |
| Storage | -20℃, protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 3 weeks |
| Stability | 1 year |
Document
Related Product

Items-$0.00

Email:
Tel.:
msds of DBCO-PEG3-paclitaxel
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


